5-HT₃ receptor antagonists in major depressive disorder: The untold tales of the underdogs

Asian J Psychiatr. 2020 Aug:52:102099. doi: 10.1016/j.ajp.2020.102099. Epub 2020 Apr 13.

Authors

Reza Rahimian¹, Gohar Fakhfouri², Mohammad Reza Zirak³

Affiliations

¹ McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University, Douglas Hospital, 6875 Boulevard LaSalle, Montreal, QC, H4H 1R3, Canada. Electronic address: [email protected].
² Department of Psychiatry, McGill University, Montreal, QC, H3A1A1, Canada.
³ Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

PMID: 32470874
DOI: 10.1016/j.ajp.2020.102099

No abstract available

Keywords: 5HT3 receptor antagonists; Depression; Neuroinflammation; Serotonin.

MeSH terms

Depressive Disorder, Major* / drug therapy
Humans
Personality
Serotonin
Serotonin 5-HT3 Receptor Antagonists

Substances

Serotonin 5-HT3 Receptor Antagonists
Serotonin